In summary, to investigate the link between NETs and SLE, using histone PTMs as prospective biomarkers, we investigated the serum reactivity profile to a panel of histone PTMs in a cohort of SLE patients and identified significant autoantibody reactivity to acetyl-histone H2B. This evidence concerns the gene H2BC21 and systemic lupus erythematosus.